This differential in glucose and lipid responsiveness has been termed “selective insulin resistance” (15), although to what extent this is due to differences in insulin action at a molecular level, modification of these pathways by circulating factors, or to differential responses to the hyperinsulinemia associated with T2D and metabolic syndrome remains a matter of debate (16, 17). This evidence concerns the gene INS and Hyperinsulinemia.